Catalyst-free synthesis of phosphinochalcogenoic anhydrides via the oxygen–chalcogen exchange with elemental sulfur or selenium
Green Chemistry · 2026 · 28 (13) · 5848-5856
DOI: 10.1039/d6gc00879h ↗Kurz gefasst
Fachartikel in der Zeitschrift Green Chemistry, 2026. Verfasst von Longzhi Zhu und 8 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, Scientific Research Fund of Hunan Provincial Education Department, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
A novel catalyst-free, three-component strategy for the synthesis of phosphinothioic/phosphinoselenoic anhydrides has been developed, employing elemental sulfur or selenium, acyl chlorides (or anhydrides), and H -phosphine oxides.
Förderung
- Natural Science Foundation of Hunan Province
- Scientific Research Fund of Hunan Provincial Education Department
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Zhu, L., Xie, S., Yang, H., Hong, Y., Chen, L., Luo, W., Jin, S., Liu, L., & Xiong, B. (2026). Catalyst-free synthesis of phosphinochalcogenoic anhydrides via the oxygen–chalcogen exchange with elemental sulfur or selenium. Green Chemistry, 28(13), 5848-5856. https://doi.org/10.1039/d6gc00879h
Vancouver
Zhu L, Xie S, Yang H, Hong Y, Chen L, Luo W, et al. Catalyst-free synthesis of phosphinochalcogenoic anhydrides via the oxygen–chalcogen exchange with elemental sulfur or selenium. Green Chemistry. 2026;28(13):5848-5856. doi:10.1039/d6gc00879h
BibTeX
@article{Zhu2026,
author = {Zhu, Longzhi and Xie, Shuangjiao and Yang, Hongbo and Hong, Yingle and Chen, Lin and Luo, Weiwei and Jin, Sha and Liu, Lixin and Xiong, Biquan},
title = {Catalyst-free synthesis of phosphinochalcogenoic anhydrides via the oxygen–chalcogen exchange with elemental sulfur or selenium},
journal = {Green Chemistry},
year = {2026},
volume = {28},
number = {13},
pages = {5848--5856},
doi = {10.1039/d6gc00879h}
}
EUVIMED